Literature DB >> 12641817

An in vitro examination of an extracellular matrix scaffold for use in wound healing.

Denis E Solomon1.   

Abstract

This paper describes evidence that an extracellular matrix (ECM) secreted by human umbilical vein endothelial cells (HUVECs) assembled on gelatin coated plates overlaid by a mixed matrix secreted by human dermal microvascular endothelial cells (HDMECs) and human dermal fibroblasts provides a viable acellular scaffold for use in wound healing. Trypsinized epidermal keratinocytes or colonies from Dispase-digested fresh and cadaver skin tissue adhered and proliferated on either HUVECs ECM/gelatin or mixed matrix overlaid on HUVECs ECM/gelatin. An epithelial-mesenchymal interaction, previously thought to be tissue-specific, was exposed as well as concomitant integrin versatility. Furthermore, heterologous HDMECs and dermal fibroblasts attached and proliferated on the mixed matrix as well as HUVECs ECM. The conditioned medium from HUVECs (HUVECs CM) was found to neutralize the lingering after effects of Dispase, and could be used for the tissue culture of epidermal keratinocytes, HDMECs and dermal fibroblasts, which share related extracellular secretions. Taken together, these results indicate that cultured epithelial autografts can be redesigned to include both epithelial and dermal elements, and advances the acellular 'sandwich' ECM scaffold as a possible structural replacement for the lamina densa and lamina lucida, damaged or completely missing in some wounds and burns.

Entities:  

Mesh:

Year:  2002        PMID: 12641817      PMCID: PMC2517685          DOI: 10.1046/j.1365-2613.2002.00238.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  24 in total

1.  The seeding of human aortic endothelial cells on the extra-cellular matrix of human umbilical vein endothelial cells.

Authors:  D E Solomon
Journal:  Int J Exp Pathol       Date:  1992-08       Impact factor: 1.925

2.  Wound closure with human keratinocytes cultured on a polyurethane dressing overlaid on a cultured human dermal replacement.

Authors:  H O Rennekampff; J F Hansbrough; V Kiessig; S Abiezzi; V Woods
Journal:  Surgery       Date:  1996-07       Impact factor: 3.982

Review 3.  Cultured cells for the treatment of disease.

Authors:  H Green
Journal:  Sci Am       Date:  1991-11       Impact factor: 2.142

4.  Current concepts in the development of cultured skin replacements.

Authors:  H O Rennekampff; V Kiessig; J F Hansbrough
Journal:  J Surg Res       Date:  1996-05       Impact factor: 2.192

5.  Specific internalization of basal membrane domains containing the integrin alpha 6 beta 4 in dispase-detached cultured human keratinocytes.

Authors:  Y Poumay; M Leclercq-Smekens; S Grailly; A Degen; R Leloup
Journal:  Eur J Cell Biol       Date:  1993-02       Impact factor: 4.492

6.  Basic fibroblast growth factor suppresses tissue plasminogen activator release from cultured human umbilical vein endothelial cells but enhances that from cultured human aortic endothelial cells.

Authors:  C Yamamoto; T Kaji; M Furuya; M Sakamoto; H Kozuka; F Koizumi
Journal:  Thromb Res       Date:  1994-02-15       Impact factor: 3.944

7.  Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.

Authors:  G Korner; T D Bjornsson; I Vlodavsky
Journal:  J Cell Physiol       Date:  1993-03       Impact factor: 6.384

8.  The extracellular matrix as a cell survival factor.

Authors:  J E Meredith; B Fazeli; M A Schwartz
Journal:  Mol Biol Cell       Date:  1993-09       Impact factor: 4.138

9.  Human keratinocytes express the three major splice forms of vascular endothelial growth factor.

Authors:  C Ballaun; W Weninger; A Uthman; H Weich; E Tschachler
Journal:  J Invest Dermatol       Date:  1995-01       Impact factor: 8.551

10.  There is binding of collagen IV to beta 1 integrin during early skin basement membrane assembly.

Authors:  R Fleischmajer; J S Perlish; E D MacDonald; A Schechter; A D Murdoch; R V Iozzo; Y Yamada
Journal:  Ann N Y Acad Sci       Date:  1998-10-23       Impact factor: 5.691

View more
  5 in total

1.  Regenerating matrix-based therapy for chronic wound healing: a prospective within-subject pilot study.

Authors:  Suzanne L Groah; Alexander Libin; Miriam Spungen; Kim-Loan Nguyen; Earthaleen Woods; Marjan Nabili; Jessica Ramella-Roman; Denis Barritault
Journal:  Int Wound J       Date:  2010-11-16       Impact factor: 3.315

2.  Blood compatible carbon nanotubes--nano-based neoproteoglycans.

Authors:  Saravanababu Murugesan; Tae-Joon Park; Hoichang Yang; Shaker Mousa; Robert J Linhardt
Journal:  Langmuir       Date:  2006-04-11       Impact factor: 3.882

3.  Characterization of partially lifted cell sheets.

Authors:  Qi Wei; Hayden Huang
Journal:  Tissue Eng Part A       Date:  2014-02-06       Impact factor: 3.845

4.  Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.

Authors:  Waleed Mohammed-Saeid; Jackson Chitanda; Mays Al-Dulaymi; Ronald Verrall; Ildiko Badea
Journal:  Pharm Res       Date:  2017-06-22       Impact factor: 4.200

5.  Elastofibroma dorsi: a histochemical and immunohistochemical study.

Authors:  A Di Vito; E Scali; G Ferraro; C Mignogna; I Presta; C Camastra; G Donato; T Barni
Journal:  Eur J Histochem       Date:  2015-02-19       Impact factor: 3.188

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.